Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1182 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Mylan revenues up 12% in Q1

The company has reported net earnings of $104.55m, compared to $94.27m for the same period prior year. For the first quarter of 2011, Mylan‘s earnings from operations was

Seavan to manufacture ALDA Pharma products

As per the agreement, ALDA Pharma’s personnel will undertake the marketing and sales of Seavan’s products and services in addition to those of ALDA. ALDA Pharma president and

Pfizer Q1 revenue marginally falls

Net income attributable to the company was $2.22bn for the first quarter of 2011, compared to $2.02bn for the same period last year. For full-year 2011, Pfizer anticipated

Catalyst Rx introduces new mobile platform

Catalyst Rx Mobile is an element of Catalyst’s Generic Advantage plan, developed after more than a year of consultation with experts in the areas of pharmacy, behavioral psychology

TCGRx introduces MedPickRx

TCGRx said MedPickRx system addresses the entire bottle formulary and reduces script fill time for the pharmacy’s entire oral solid formulary by up to 40% which represents 92%